---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-021417"
form_type: "8-K"
ticker: "VKTX"
cik: "0001607678"
company_name: "Viking Therapeutics, Inc."
filed_at: "2022-05-26T23:59:59+00:00"
generated_at: "2026-06-25T06:47:02.605352+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Viking Therapeutics shareholders elect directors, ratify auditor, approve say-on-pay at 2022 annual meeting

## Summary
- Elected Matthew W. Foehr and Charles A. Rowland, Jr. as Class I directors; Foehr received 17.1M votes for, Rowland 16.3M.
- Ratified Marcum LLP as independent auditor for FY2022 with 50.7M votes for, 0.4M against, 66K abstentions.
- Advisory vote on named executive officer compensation passed with 25.2M for, 1.7M against, 0.9M abstain.
- Broker non-votes of about 23.4M shares on director elections and say-on-pay due to uninstructed shares.

## SEC filing metadata
- accession: 0001564590-22-021417
- form_type: 8-K
- ticker: VKTX
- cik: 0001607678
- company_name: Viking Therapeutics, Inc.
- filed_at: 2022-05-26T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1607678/000156459022021417/0001564590-22-021417-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1607678/000156459022021417/vktx-8k_20220524.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-021417
- JSON: https://secwatch.observer/filing/0001564590-22-021417.json
- Plain text: https://secwatch.observer/filing/0001564590-22-021417.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.